Tue, 26 Sep 2017 11:20:36: Despite hope and hype, Axovant serves up another failed Alzheimer’s med

Mon, 25 Sep 2017 15:45:31: Eligo raises $20M to take bacteria-killing CRISPR drug into clinic

Mon, 25 Sep 2017 12:26:46: Boost for Exelixis as partner Daiichi Sankyo cues up hypertension drug filing

Mon, 25 Sep 2017 11:57:11: AstraZeneca, NewLink pen PD-L1 and IDO combination pact

Mon, 25 Sep 2017 11:05:15: Sensor captures bacteria's movements to measure antibiotic efficacy

Mon, 25 Sep 2017 10:04:06: FDA rejects Johnson & Johnson’s rheumatoid arthritis drug sirukumab on safety grounds, demands more data

Mon, 25 Sep 2017 09:09:48: Pfizer launches upstart with $103M, phase 3-ready drugs

Fri, 22 Sep 2017 12:43:43: AbbVie pairs up another ADC cancer drug with Bristol-Myers Squibb's Opdivo

Fri, 22 Sep 2017 08:05:43: Phase 3 flop puts Versartis on life support

Fri, 22 Sep 2017 07:17:44: Nestlé to ax up to 450 skin health R&D jobs, exit facility

Thu, 21 Sep 2017 18:37:08: Chutes & Ladders—Ex-GlaxoSmithKline CEO Witty joins venture capital

Thu, 21 Sep 2017 13:39:03: EuroBiotech Report—Bavarian Nordic, Nabriva, Immunocore, Glythera-Iontas and Sanofi

Thu, 21 Sep 2017 13:10:06: Celgene-backed FLX picks CCR4 antagonist for clinical trials

Thu, 21 Sep 2017 12:05:14: Janssen deal gives new kid in town Provention two immune candidates

Thu, 21 Sep 2017 10:35:00: First biotech emerges from Garabedian’s accelerator armed with $10M, plans to tackle autoimmune diseases

Wed, 20 Sep 2017 16:27:05: Sanofi and NIH chart early success with 3-part antibody against HIV

Wed, 20 Sep 2017 13:31:12: Lightstone goes over target with new $250M biotech fund

Wed, 20 Sep 2017 13:09:48: China’s WuXi, Johnson & Johnson-backed XW Labs lands $17.5M series B

Wed, 20 Sep 2017 12:56:14: Arcus' cancer portfolio attracts $35M option deal from Japan's Taiho

Wed, 20 Sep 2017 12:48:34: How poliovirus unleashes an attack on glioblastoma

Wed, 20 Sep 2017 12:36:34: Glythera taps Iontas for antibodies to guide next-generation ADCs

Wed, 20 Sep 2017 12:26:44: Alnylam’s patisiran hits all endpoints in critical phase 3

Tue, 19 Sep 2017 13:14:45: Aerie raids Alcon again, returning this time with an R&D VP

Tue, 19 Sep 2017 12:42:52: Acceleron takes back drug rights from Celgene to start pulmonary push

Tue, 19 Sep 2017 10:48:37: Ex-GlaxoSmithKline CEO Witty joins Hatteras as venture partner